<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="is properly cited. Abstract Influenza is a very important respiratory" exact="infectious disease" post="that causes seasonal epidemics and pandemics. A well-organized surveillance"/>
 <result pre="the epidemiologic features of influenza. Korea currently operates a national" exact="influenza" post="surveillance system based on the clinical sentinel surveillance system,"/>
 <result pre="related to influenza. This article discusses the general aspects of" exact="influenza" post="surveillance systems and the future direction of the national"/>
 <result pre="influenza surveillance systems and the future direction of the national" exact="influenza" post="surveillance system of Korea. Influenza Human Sentinel surveillance Population"/>
 <result pre="Population surveillance Korea Introduction Influenza is a very important respiratory" exact="infectious disease" post="that causes seasonal epidemics globally and annually among people"/>
 <result pre="but also causes pandemics every 10 to 40 years. Thus," exact="influenza" post="is considered as one of the most important among"/>
 <result pre="surveillance system is necessary to monitor and respond effectively to" exact="influenza" post="epidemics. An influenza surveillance system is useful for identifying"/>
 <result pre="necessary to monitor and respond effectively to influenza epidemics. An" exact="influenza" post="surveillance system is useful for identifying influenza epidemics, the"/>
 <result pre="influenza epidemics. An influenza surveillance system is useful for identifying" exact="influenza" post="epidemics, the nature of the virus, and the burden"/>
 <result pre="of disease, as well as determining the policies aimed at" exact="influenza" post="epidemic control, vaccine selection, and the development of guidelines"/>
 <result pre="development of guidelines for the use of antiviral drugs. An" exact="influenza" post="surveillance system can also be used to monitor influenza"/>
 <result pre="An influenza surveillance system can also be used to monitor" exact="influenza" post="pandemics and new respiratory infectious diseases. Korea currently operates"/>
 <result pre="and new respiratory infectious diseases. Korea currently operates a national" exact="influenza" post="surveillance system based on the clinical sentinel surveillance system,"/>
 <result pre="pieces of information related to influenza. This article reviews the" exact="influenza" post="surveillance system characteristics, foreign surveillance systems, including those of"/>
 <result pre="Health Organization (WHO) and the United States (US), and the" exact="influenza" post="surveillance system of Korea. It further discusses the future"/>
 <result pre="Korea. It further discusses the future direction of the national" exact="influenza" post="surveillance system of Korea. Influenza surveillance systems in general"/>
 <result pre="or passive or active surveillance systems [4]. In countries operating" exact="influenza" post="surveillance systems, the most common form is active sentinel"/>
 <result pre="and laboratory data [5678]. There are two major forms of" exact="influenza" post="surveillance systems: clinical sentinel surveillance and virologic sentinel surveillance"/>
 <result pre="[9]. A clinical sentinel surveillance system is used to identify" exact="influenza" post="outbreaks and epidemics, establish a vaccination plan, initiate antiviral"/>
 <result pre="other indicators can be used that represent the burden of" exact="influenza" post="in the community such as absenteeism, or that show"/>
 <result pre="community such as absenteeism, or that show the severity of" exact="influenza" post="or burden from the healthcare perspective such as emergency"/>
 <result pre="OPD-based surveillance systems are used to determine the occurrence of" exact="influenza" post="epidemics by monitoring the ratio of the number of"/>
 <result pre="distribution and population characteristics among OPD clinics that directly treat" exact="influenza" post="patients. The selected sites report the information of patients"/>
 <result pre="participating sites, virologic surveillance data, geographical and demographic characteristics, and" exact="influenza" post="vaccination rate. The hospitalization-based surveillance system contributes to the"/>
 <result pre="contributes to the understanding of the severity and burden of" exact="influenza" post="by monitoring cases of severe acute respiratory illness (SARI),"/>
 <result pre="progression than other respiratory viruses. The main anticipated effect of" exact="influenza" post="vaccination is to reduce the burden of influenza. Therefore,"/>
 <result pre="determine the appropriateness and evaluate the effectiveness of policies for" exact="influenza" post="control. Data collected through both surveillance systems can be"/>
 <result pre="collected through both surveillance systems can be used to assess" exact="influenza" post="vaccine effectiveness. However, a procedure for increasing the accuracy"/>
 <result pre="vaccine effectiveness. However, a procedure for increasing the accuracy of" exact="influenza" post="vaccination history is required to evaluate the influenza vaccine"/>
 <result pre="accuracy of influenza vaccination history is required to evaluate the" exact="influenza" post="vaccine effectiveness accurately. In addition, a sufficient number of"/>
 <result pre="the vaccine effect by virus type/subtypes and age groups. Foreign" exact="influenza" post="surveillance systems 1. World Health Organization The WHO discussion"/>
 <result pre="Health Organization The WHO discussion on the operation of the" exact="influenza" post="network began in 1951 at a conference held in"/>
 <result pre="Pandemic Influenza Preparedness Framework was adopted, which involved sharing of" exact="influenza" post="virus characteristics and other benefits of vaccines, and its"/>
 <result pre="and Response System (GISRS). The GISRS consists of 144 national" exact="influenza" post="centers, 6 WHO collaborating centers (CCs), 4 essential regulatory"/>
 <result pre="13 H5 reference laboratories (H5RefLabs) as of 2019 [11]. National" exact="influenza" post="centers collect virus specimens, and ship representative clinical specimens"/>
 <result pre="antigenic and genetic analysis. The WHO recommends the composition of" exact="influenza" post="vaccines based on the results of the analysis. WHO"/>
 <result pre="the six WHO CCs is responsible for surveillance, epidemiology, and" exact="influenza" post="prevention. Essential regulatory laboratories have the critical function of"/>
 <result pre="critical function of connecting surveillance and risk assessment activities with" exact="influenza" post="vaccine response. H5RefLabs were established in 2004, in response"/>
 <result pre="2004, in response to the public health needs arising from" exact="avian influenza" post="A/H5N1 infection in humans and influenza pandemic preparedness. H5RefLabs"/>
 <result pre="in response to the public health needs arising from avian" exact="influenza" post="A/H5N1 infection in humans and influenza pandemic preparedness. H5RefLabs"/>
 <result pre="needs arising from avian influenza A/H5N1 infection in humans and" exact="influenza" post="pandemic preparedness. H5RefLabs collect and analyze influenza A/H5N1 or"/>
 <result pre="in humans and influenza pandemic preparedness. H5RefLabs collect and analyze" exact="influenza" post="A/H5N1 or other influenza subtypes that can potentially cause"/>
 <result pre="pandemic preparedness. H5RefLabs collect and analyze influenza A/H5N1 or other" exact="influenza" post="subtypes that can potentially cause human infections. The data"/>
 <result pre="database and presented via FluNet, a global web-based tool for" exact="influenza" post="virologic surveillance first launched in 1997. The virologic data"/>
 <result pre="[12]. Thus, in many countries, data on the burden of" exact="influenza" post="are being prepared [13141516]. 2. United States The US"/>
 <result pre="five categories of information from eight different data sources on" exact="influenza" post="activity year-round: virologic surveillance, outpatient illness surveillance, summary of"/>
 <result pre="weekly total number of specimens tested, the number of positive" exact="influenza" post="test results, and the percentage of positive test results"/>
 <result pre="test results, and the percentage of positive test results by" exact="influenza" post="virus type. Public health laboratories also report other kinds"/>
 <result pre="weekly total number of specimens tested, the number of positive" exact="influenza" post="test results, and the number by influenza virus type,"/>
 <result pre="number of positive influenza test results, and the number by" exact="influenza" post="virus type, subtype, and influenza B lineage. Outpatient illness"/>
 <result pre="results, and the number by influenza virus type, subtype, and" exact="influenza" post="B lineage. Outpatient illness surveillance. Information on outpatient visits"/>
 <result pre="departments report the estimated level of the geographic spread of" exact="influenza" post="activity in their states each week through the State"/>
 <result pre="each week through the State and Territorial Epidemiologists Reports. The" exact="influenza" post="activity is classified at five levels: no activity, sporadic,"/>
 <result pre="Influenza. Each state reports on the weekly geographic spread of" exact="influenza" post="activity through the State and Territorial Epidemiologists Reports. Influenza"/>
 <result pre="Influenza Hospitalization Surveillance Network monitors laboratory-confirmed influenza-associated hospitalization. During the" exact="influenza" post="season, data are collected from cases with laboratory-confirmed influenza."/>
 <result pre="mortality surveillance system. The National Center for Health Statistics collects" exact="pneumonia" post="and influenza mortality data from each state based on"/>
 <result pre="system. The National Center for Health Statistics collects pneumonia and" exact="influenza" post="mortality data from each state based on ICD-10 codes."/>
 <result pre="from each state based on ICD-10 codes. The seasonal baseline" exact="pneumonia" post="and influenza mortality rate is estimated using a periodic"/>
 <result pre="state based on ICD-10 codes. The seasonal baseline pneumonia and" exact="influenza" post="mortality rate is estimated using a periodic regression model."/>
 <result pre="2004, deaths among children younger than 18 years with laboratory-confirmed" exact="influenza" post="have been added as a nationally notifiable condition. In"/>
 <result pre="been operating a vaccine effectiveness surveillance [18]. Surveillance for monitoring" exact="influenza" post="vaccine effectiveness is managed separately by the US Flu"/>
 <result pre="At the participating sites, respiratory specimens are collected for isolating" exact="influenza" post="viruses together with demographic and medical information, including underlying"/>
 <result pre="together with demographic and medical information, including underlying diseases and" exact="influenza" post="vaccination history. The two networks assess and report influenza"/>
 <result pre="and influenza vaccination history. The two networks assess and report" exact="influenza" post="vaccine effectiveness separately during each season [1920]. The US"/>
 <result pre="each season [1920]. The US CDC calculates and reports the" exact="influenza" post="disease burden using the Influenza surveillance data, and the"/>
 <result pre="aim of the EISN is to contribute to reducing the" exact="influenza" post="burden in Europe. The EISN originated in the European"/>
 <result pre="member states in Europe. Each member state has a separate" exact="influenza" post="surveillance system and case definition for the surveillance. The"/>
 <result pre="influenza-positive cases from intensive care units. 4. Japan The national" exact="influenza" post="surveillance system of Japan is affiliated to the National"/>
 <result pre="sentinel surveillance systems for various kinds of infectious diseases including" exact="influenza" post="[23]. The sentinel outpatient surveillance system has been applied"/>
 <result pre="[23]. The sentinel outpatient surveillance system has been applied to" exact="influenza" post="surveillance. Sentinel sites were designated according to the geographic"/>
 <result pre="with ILI every week. Virologic surveillance, consisting of testing for" exact="influenza" post="virus and the analysis of viral antigenicity, is incorporated"/>
 <result pre="for hospitalization surveillance. Japan has monitored the incidence of influenza-associated" exact="encephalopathy" post="since the late 1990s. Japan has a surveillance system"/>
 <result pre="school closures. The law of Japan states that children with" exact="influenza" post="infection should stay home for at least 6 days"/>
 <result pre="the school can be closed to stop the transmission of" exact="influenza" post="depending on the size of influenza outbreaks. In addition"/>
 <result pre="stop the transmission of influenza depending on the size of" exact="influenza" post="outbreaks. In addition to the surveillance system operated by"/>
 <result pre="is organized by volunteer clinicians who report the number of" exact="influenza" post="patients diagnosed at their clinics through the ML-Influenza Database."/>
 <result pre="diagnosed at their clinics through the ML-Influenza Database. The current" exact="influenza" post="surveillance system of Korea The influenza surveillance system of"/>
 <result pre="ML-Influenza Database. The current influenza surveillance system of Korea The" exact="influenza" post="surveillance system of Korea was initiated in October 1997"/>
 <result pre="since 2000 to the Korea Influenza Surveillance Scheme. Currently, the" exact="influenza" post="surveillance system operated by the Korea CDC consists of"/>
 <result pre="surveillance (Korea Influenza and Respiratory Virus Surveillance System [KINRESS]), and" exact="influenza" post="hospitalization and mortality surveillance systems [24]. Clinical sentinel surveillance."/>
 <result pre="of the following year. The data are used to identify" exact="influenza" post="epidemics in Korea. Laboratory sentinel surveillance. KINRESS is operated"/>
 <result pre="reexamination of unidentified specimens. Based on these results, the circulating" exact="influenza" post="viruses in Korea are identified, and the characteristics of"/>
 <result pre="patients diagnosed with influenza. Medical histories are also collected, including" exact="influenza" post="vaccination history, underlying medical condition, travel history, and the"/>
 <result pre="have been used to analyze the clinical course of severe" exact="influenza" post="[2627], influenza disease burden [28], characteristics of influenza viruses"/>
 <result pre="used to analyze the clinical course of severe influenza [2627]," exact="influenza" post="disease burden [28], characteristics of influenza viruses that caused"/>
 <result pre="of severe influenza [2627], influenza disease burden [28], characteristics of" exact="influenza" post="viruses that caused severe clinical course [29], influenza vaccine"/>
 <result pre="characteristics of influenza viruses that caused severe clinical course [29]," exact="influenza" post="vaccine effectiveness, and so on. In addition to surveillance"/>
 <result pre="addition to surveillance for severe influenza, there is surveillance for" exact="avian influenza" post="viruses that can cause human infection such as A/H7N9"/>
 <result pre="to surveillance for severe influenza, there is surveillance for avian" exact="influenza" post="viruses that can cause human infection such as A/H7N9"/>
 <result pre="to be operated at nine hospitals. The future direction of" exact="influenza" post="surveillance systems in Korea Influenza comprises not only a"/>
 <result pre="part of the government budget has been used to target" exact="influenza" post="vaccination. Influenza vaccination among the elderly has been included"/>
 <result pre="immunization program from the 2019–2020 season. Considering the impact of" exact="influenza" post="and the continuous change in the characteristics of influenza"/>
 <result pre="of influenza and the continuous change in the characteristics of" exact="influenza" post="viruses, a proper surveillance system is essential in Korea."/>
 <result pre="a proper surveillance system is essential in Korea. The national" exact="influenza" post="surveillance system currently operated by the government has played"/>
 <result pre="by the government has played an important role in identifying" exact="influenza" post="epidemic patterns and virus characteristics in Korea. However, it"/>
 <result pre="KCDC provides a limited understanding of the characteristics of serious" exact="influenza" post="and its disease burden. The hospitalization and mortality surveillance"/>
 <result pre="difficult to identify the characteristics of viruses associated with severe" exact="influenza" post="because specimens are not collected. If it is not"/>
 <result pre="of influenza. In the US, when assessing the burden of" exact="influenza" post="illness, the spectrum of influenza from mild to dead"/>
 <result pre="when assessing the burden of influenza illness, the spectrum of" exact="influenza" post="from mild to dead is estimated based on hospitalized"/>
 <result pre="Another limitation is the difficulty in assessing the effectiveness of" exact="influenza" post="vaccines. Although information regarding influenza vaccination history has been"/>
 <result pre="in assessing the effectiveness of influenza vaccines. Although information regarding" exact="influenza" post="vaccination history has been collected, the reliability of the"/>
 <result pre="outpatients and inpatients. An example is the surveillance system for" exact="influenza" post="vaccine effectiveness in the US. The assessment of the"/>
 <result pre="effectiveness in the US. The assessment of the burden of" exact="influenza" post="and the evaluation of the vaccine effectiveness is very"/>
 <result pre="cannot fulfill every purpose. To meet the unmet need of" exact="influenza" post="surveillance in Korea, therefore, it does not simply suffice"/>
 <result pre="simply suffice to adjust the data collected from the existing" exact="influenza" post="surveillance system. The national influenza surveillance system currently operated"/>
 <result pre="data collected from the existing influenza surveillance system. The national" exact="influenza" post="surveillance system currently operated in Korea is relatively well-organized"/>
 <result pre="However, more needs to be done to better cope with" exact="influenza" post="considering the influenza situation of Korea and foreign surveillance"/>
 <result pre="to be done to better cope with influenza considering the" exact="influenza" post="situation of Korea and foreign surveillance systems. A better"/>
 <result pre="support proper policy making and produce enough scientific evidence regarding" exact="influenza" post="control. Conflict of Interest: No conflicts of interest. References"/>
 <result pre="Economic Area countries, 2009 to 2013Euro Surveill2018231700454 2GrossPAHermogenesAWSacksHSLauJLevandowskiRAThe efficacy of" exact="influenza" post="vaccine in elderly persons. A meta-analysis and review of"/>
 <result pre="literatureAnn Intern Med19951235185277661497 3DollMKWintersNBoikosCKraicer-MelamedHGoreGQuachCSafety and effectiveness of neuraminidase inhibitors for" exact="influenza" post="treatment, prophylaxis, and outbreak control: a systematic review of"/>
 <result pre="Med Public Health20074025926417693727 5SanicasMForleoEPozziGDiopDA review of the surveillance systems of" exact="influenza" post="in selected countries in the tropical regionPan Afr Med"/>
 <result pre="in the tropical regionPan Afr Med J20141912125745529 6ThommesEWKruseMKohliMSharmaRNoorduynSGReview of seasonal" exact="influenza" post="in Canada: Burden of disease and the cost-effectiveness of"/>
 <result pre="Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated" exact="influenza" post="vaccinesHum Vaccin Immunother20171386787627858509 7SambalaEZNdwandweDEImaanLMWiysongeCSEvaluation of influenza surveillance systems in"/>
 <result pre="cost-effectiveness of quadrivalent inactivated influenza vaccinesHum Vaccin Immunother20171386787627858509 7SambalaEZNdwandweDEImaanLMWiysongeCSEvaluation of" exact="influenza" post="surveillance systems in sub-Saharan Africa: a systematic review protocolBMJ"/>
 <result pre="sub-Saharan Africa: a systematic review protocolBMJ Open20199e023335 8YangPDuanWLvMShiWPengXWangXLuYLiangHSealeHPangXWangQReview of an" exact="influenza" post="surveillance system, Beijing, People's Republic of ChinaEmerg Infect Dis2009151603160819861053"/>
 <result pre="9KimWJNohJYParkMSSongJYShinOAhnDHWieSHLeeJSJangJCheongHJChunBCChoiYKChoiWSInfluenzaSeoulTransgovernmental Enterprise for Pandemic Influenza in Korea2016 10ZieglerTMamahitACoxNJ65 years of" exact="influenza" post="surveillance by a World Health Organization-coordinated global networkInfluenza Other"/>
 <result pre="Organization-coordinated global networkInfluenza Other Respir Viruses201812558565 11collab: World Heaith OrganizationGlobal" exact="influenza" post="surveillance and response system (GISRS)Accessed 22 April 2019Available at:"/>
 <result pre="12ChaiyakunaprukNKotirumSNewallATLambachPHutubessyRCWRationale and opportunities in estimating the economic burden of seasonal" exact="influenza" post="across countries using a standardized WHO tool and manualInfluenza"/>
 <result pre="Viruses201812132129143498 13OlivaJDelgado-SanzCLarrauriAcollab: Spanish Influenza Surveillance SystemEstimating the burden of seasonal" exact="influenza" post="in Spain from surveillance of mild and severe influenza"/>
 <result pre="seasonal influenza in Spain from surveillance of mild and severe" exact="influenza" post="disease, 2010-2016Influenza Other Respir Viruses20181216117028960828 14SchanzerDLSabouiMLeeLNwosuABancejCBurden of influenza, respiratory"/>
 <result pre="respiratory inpatients, Canada, 2003-2014Influenza Other Respir Viruses20181211312129243369 15SimmermanJMUyekiTMThe burden of" exact="influenza" post="in East and South-East Asia: a review of the"/>
 <result pre="Infect Dis2018241173117729912681 17collab: Centers for Disease Control and PreventionOverview of" exact="influenza" post="surveillance in the United StatesAccessed 22 April 2019Available at:"/>
 <result pre="2019Available at: https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm 19TreanorJJTalbotHKOhmitSEColemanLAThompsonMGChengPYPetrieJGLofthusGMeeceJKWilliamsJVBermanLBreese HallCMontoASGriffinMRBelongiaEShayDKcollab: US Flu-VE NetworkEffectiveness of seasonal" exact="influenza" post="vaccines in the United States during a season with"/>
 <result pre="three vaccine strainsClin Infect Dis20125595195922843783 20FerdinandsJMGaglaniMMartinETMiddletonDMontoASMurthyKSilveiraFPTalbotHKZimmermanRAlyanakEStricklandCSpencerSFryAMcollab: HAIVEN Study InvestigatorsPrevention of" exact="influenza" post="hospitalization among adults in the US, 2015-16: Results from"/>
 <result pre="ahead of print 21RolfesMAFoppaIMGargSFlanneryBBrammerLSingletonJABurnsEJerniganDOlsenSJBreseeJReedCAnnual estimates of the burden of seasonal" exact="influenza" post="in the United States: a tool for strengthening influenza"/>
 <result pre="seasonal influenza in the United States: a tool for strengthening" exact="influenza" post="surveillance and preparednessInfluenza Other Respir Viruses20181213213729446233 22collab: European Centre"/>
 <result pre="Respir Viruses20181213213729446233 22collab: European Centre for Disease Prevention and ControlEuropean" exact="influenza" post="surveillance network (EISN)Accessed 2 April 2019Available at: https://ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/eisn 23ZaraketHSaitoRJapanese"/>
 <result pre="24collab: Korea Centers for Disease Control and Prevention (KCDC)2018-2019 season" exact="influenza" post="management guidelineOsongKCDC2018 25SeoYBSongJYCheongHJChoYDWieSHJeongHWKimWJHospital-based influenza morbidity and mortality surveillance system"/>
 <result pre="Disease Control and Prevention (KCDC)2018-2019 season influenza management guidelineOsongKCDC2018 25SeoYBSongJYCheongHJChoYDWieSHJeongHWKimWJHospital-based" exact="influenza" post="morbidity and mortality surveillance system for influenza-like illnesses: a"/>
 <result pre="mortality surveillance system for influenza-like illnesses: a comparison with national" exact="influenza" post="surveillance systemsInfluenza Other Respir Viruses20148172024020512 26HongKWCheongHJChoiWSLeeJWieSHBaekJHKimHYJeongHWKimWJClinical courses and outcomes"/>
 <result pre="26HongKWCheongHJChoiWSLeeJWieSHBaekJHKimHYJeongHWKimWJClinical courses and outcomes of hospitalized adult patients with seasonal" exact="influenza" post="in Korea, 2011-2012: Hospital-based Influenza Morbidity &amp;amp; Mortality (HIMM)"/>
 <result pre="27KangSHCheongHJSongJYNohJYJeonJHChoiMJLeeJSeoYBLeeJSWieSHJeongHWKimYKParkKHKimSWJeongEJLeeSHChoiWSKimWJAnalysis of risk factors for severe acute respiratory infection and" exact="pneumonia" post="and among adult patients with acute respiratory illness during"/>
 <result pre="and among adult patients with acute respiratory illness during 2011-2014" exact="influenza" post="seasons in KoreaInfect Chemother20164829430127883375 28ChoiWSCowlingBJNohJYSongJYWieSHLeeJSSeoYBLeeJJeongHWKimYKKimSWParkKHLeeSHCheongHJKimWJDisease burden of 2013-2014 seasonal"/>
 <result pre="influenza seasons in KoreaInfect Chemother20164829430127883375 28ChoiWSCowlingBJNohJYSongJYWieSHLeeJSSeoYBLeeJJeongHWKimYKKimSWParkKHLeeSHCheongHJKimWJDisease burden of 2013-2014 seasonal" exact="influenza" post="in adults in KoreaPLoS One201712e017201228278158 29LeeHSNohJYSongJYCheongHJChoiWSJeongHWWieSHKimWJMolecular genetic characteristics of"/>
 <result pre="influenza in adults in KoreaPLoS One201712e017201228278158 29LeeHSNohJYSongJYCheongHJChoiWSJeongHWWieSHKimWJMolecular genetic characteristics of" exact="influenza" post="A virus clinically isolated during 2011-2016 influenza seasons in"/>
 <result pre="genetic characteristics of influenza A virus clinically isolated during 2011-2016" exact="influenza" post="seasons in KoreaInfluenza Other Respir Viruses20181249750729489060 30SongJYNohJYLeeJWooHJLeeJSWieSHKimYKJeongHWKimSWLeeSHParkKHKangSHKeeSYKimTHChooEJLeeHSChoiWSCheongHJKimWJHospital-based influenza morbidity"/>
 <result pre="during 2011-2016 influenza seasons in KoreaInfluenza Other Respir Viruses20181249750729489060 30SongJYNohJYLeeJWooHJLeeJSWieSHKimYKJeongHWKimSWLeeSHParkKHKangSHKeeSYKimTHChooEJLeeHSChoiWSCheongHJKimWJHospital-based" exact="influenza" post="morbidity and mortality (HIMM) surveillance for A/H7N9 influenza virus"/>
 <result pre="Viruses20181249750729489060 30SongJYNohJYLeeJWooHJLeeJSWieSHKimYKJeongHWKimSWLeeSHParkKHKangSHKeeSYKimTHChooEJLeeHSChoiWSCheongHJKimWJHospital-based influenza morbidity and mortality (HIMM) surveillance for A/H7N9" exact="influenza" post="virus infection in returning travelersJ Korean Med Sci201833e4929359537 31collab:"/>
</results>
